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MDR TB  
Transmission,  
Singapore
To the Editor: Over the past 
decade, the proportion of pulmo-
nary multidrug-resistant tuberculosis 
(MDR TB) cases among Singapore-
born patients remained low, whereas 
that among foreign-born patients was 
10 times higher (1,2). Since 2005, 
Singapore has experienced a sharp in-
crease in the number of MDR TB cas-
es from high-prevalence countries (3). 
We report local transmission of MDR 
TB in 2011, from a short-stay visitor 
to 2 Singapore-born persons in a cor-
rectional setting.
The index case-patient was a 
34-year-old Burmese man (patient A) 
arrested 10 months after entering Sin-
gapore. A screening radiograph taken 
2 days after arrest showed a right up-
per lobe cavitary lesion. The man was 
referred to the TB Control Unit. He 
had been coughing for 3 months but 
had no other concurrent conditions. 
When the abnormal radiograph results 
became known, the man was isolated 
within the prison. Sputum was collect-
ed, and first-line anti-TB drugs were 
administered pending sputum results. 
The sputum smear had 3+ acid-fast 
bacilli (AFB); mutations of the rpoB 
and katG genes were indicated by test-
ing with GenoType MTDRplus (Hain 
Lifescience, Nehren, Germany). The 
patient’s treatment regimen was modi-
fied accordingly; appropriate second-
line anti-TB treatment was started 14 
days after he entered the institution. 
Mycobacterium tuberculosis complex 
(MTC) grew from sputum in 9 days; 
phenotypic drug-susceptibility test-
ing (DST) demonstrated resistance to 
rifampin, isoniazid, streptomycin, and 
ethambutol and susceptibility to pyra-
zinamide, ethionamide, kanamycin, 
and ofloxacin.
One month after patient A was 
arrested, a Singapore-born man (pa-
tient B) in a public hospital received 
a diagnosis of HIV infection (67 CD4 
cells/mL) and Pneumocystis jirovecii 
pneumonia. He was not an identified 
contact of patient A, although his job 
entailed accompanying prisoners from 
remand centers to justice courts. An-
tiretroviral treatment (ART) given 1 
month after HIV diagnosis resulted in 
fever 7 days later. A repeat chest ra-
diograph showed increased opacities 
in the left upper zone. Sputum smear 
was 4+ for AFB, and MTC with rpoB 
gene mutation was detected (Xpert 
MTB/RIF; Cepheid, Sunnyvale CA, 
USA). Second-line anti-TB drugs 
were administered. MTC was grown 
in sputum and blood in 14 and 32 
days, respectively; phenotypic DST 
8 weeks later showed a susceptibility 
profile that was identical (except for 
ethambutol susceptibility) to that of 
patient A.
Patient C was a 43-year-old Singa-
pore-born man arrested 1 month after 
receiving an HIV diagnosis and begin-
ning ART. He withheld his HIV status 
from prison authorities. He shared a 
cell with patient A for ≈48 hours at 
the remand center before the chest ra-
diograph for patient A was taken. Pa-
tient C was released after 2 days and 
screened as a contact 2 months later; 
CD4 count was <20 cells/mL despite 
ART. Physical examination showed 
peripheral lymphadenopathy. T-SPOT.
TB test (Oxford Immunotec Ltd., 
Abingdon, UK) result was negative, 
chest radiographs were unremarkable, 
and 2 sputum smears were negative 
for AFB (corresponding specimens 
for TB culture were negative). These 
findings were communicated to the 
patient’s primary physician. He was 
hospitalized 3 months later with fever 
and cough for 5 days but discharged 
himself, against medical advice, after 
2 days. After 11 days, he was readmit-
ted in septic shock to another hospital, 
at which time his sputum smear was 
positive for AFB and chest radiograph 
showed an increased right paratrache-
al stripe with right lower zone opaci-
ties. A bronchoesophageal fistula was 
also diagnosed, for which he declined 
intervention. Isoniazid, ethambutol, 
pyrazinamide, and rifabutin (his sec-
ond-line ART regimen was incompat-
ible with rifampin) were prescribed, 
and he discharged himself, against 
medical advice. After 5 days, he was 
readmitted with worsening cough; 
second-line anti-TB medications were 
instituted when his sputum specimen 
results were reported 8 weeks later 
as being phenotypically resistant to 
rifampin, isoniazid, and streptomy-
cin. DST results for ethambutol were 
discrepant for isolates cultured from 
2 sputum specimens and tested in 
2 laboratories.
DNA genotyping by spoligo-
typing (Ocimum Biosolutions, Hy-
derabad, India) (4) showed that the 
isolates from all 3 patients belonged 
to type 467 H3, according to the 
SITVIT2 database (www.pasteur-
guadeloupe.fr:8081/SITVITDemo/). 
Mycobacterial interspersed repetitive 
units–variable number tandem re-
peat genotyping with a 24-loci panel 
(Genoscreen, Lille, France) (5) simi-
larly showed identical profiles (Fig-
ure). No other isolates in our database 
had matching profiles.
The cases reported here echo pre-
vious institutional outbreaks of MDR 
TB in industrialized countries (6–8). 
They are a reminder of the potentially 
devastating consequences when HIV 
and MDR TB intersect and the need 
for infection control measures where 
vulnerable and/or high-risk groups 
congregate. For patients A and B, rap-
id genotypic DST expedited the MDR 
TB diagnosis and institution of ap-
propriate treatment and isolation mea-
sures and curtailed further spread. The 
unmasking immune reconstitution in-
flammatory syndrome that developed 
in patient B exemplifies the need for 
TB screening before starting ART in 
patients from countries with medium-
to-high TB prevalence. For patient 
C, the several-week delay in insti-
tuting second-line TB medications 




medical teams been aware of his re-
cent MDR TB exposure.
A recent update documented the 
highest rates of global MDR TB in 
2009 and 2010 (9). Our experience re-
ported here underscores the need to be 
constantly mindful of this infectious 
disease threat in our increasingly bor-
derless world, even in countries where 
incidence of MDR TB is low.
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Human Infection 
with Marten  
Tapeworm
To the Editor: Cysticercosis-like 
human infections with the tapeworm 
Taenia crassiceps, which infects foxes 
as terminal hosts, have been reported 
(1,2). We report a case of a cysticer-
cosis-like eye infection caused by 
the tapeworm T. martis (marten tape-
worm) in a woman.
The patient was a 43-year-old Ger-
man woman who sought care during 
July 2010, after 4 days of perceiving 
flashing lights in her visual field and a 
paracentral scotoma in her left eye. Vi-
sual acuity in both eyes was 20/20. Ex-
amination of the left fundus revealed a 
mobile subretinal tumor at the temporal 
upper retinal branch vessel with adja-
cent intraretinal and subhyaloid bleed-
ing (Figure, panels A–C; online Video, 
wwwnc.cdc.gov/EID/article/19/7/12-
1114-F1.htm). The subretinal tumor 
resembled a cestode larva. 
The patient reported no other 
symptoms at that time. Laboratory 
evaluation found no eosinophilia 
or elevation of total IgE. Serologic 
testing results were negative for an-
tibodies against the following para-
sites: Taenia solium, Echinococcus 
multilocularis, E. granulosus, Dirofi-
laria immitis, Strongyloides spp., and 
Toxocara canis. Fecal testing results 
were negative for worm eggs. Images 
from ultrasonography of the liver 
and magnetic resonance imaging of 
the head were unremarkable. The 
patient’s travel history included—in 
addition to southern European coun-
tries—trips to Nepal and Thailand 15 
years previously. 
At the time of examination, the 
patient lived in a small village near 
Freiburg (im Breisgau) in southwest-
ern Germany. She grew vegetables in 
the family garden, which was next to a 
forest. Her 3 children and husband did 
not report any health problems. For 
the past 6 years, the family had owned 
Figure.	Spoligotype	and	24-loci	MIRU-VNTR	typing	results	for	Mycobacterium tuberculosis 
complex	 isolates	 recovered	 from	 3	 patients	 with	 multidrug-resistant	 tuberculosis	 (TB).	
Patient	 A	 (index	 case-patient),	 Burma-born	 man	 with	 TB,	 incarcerated	 in	 Singapore	
correctional	 facility;	 patient	 B,	 Singapore-born	 man	 with	 HIV	 infection	 and	 TB,	 who	
transported	prisoners	in	Singapore;	patient	C,	Singapore-born	man	with	HIV	infection	and	
TB,	 who	 shared	 cell	 with	 patient	A.	MIRU-VNTR,	mycobacterial	 interspersed	 repetitive	
units–variable	number	tandem	repeat.
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